Cardiovascular Drugs Practice Questions

Q: Quinidine is used to treat which of the following conditions?

Atrial fibrillation. **Explanation:** **Quinidine** is a **Class IA antiarrhythmic** drug [1], [2]. It works by blocking open sodium (Na+) channels, which decreases the rate of rise of the action potential (Phase 0) and slows conduction velocity. Additionally, it blocks potassium (K+) channels, prolonging the action potential duration and the effective refractory period (ERP) [2]. 1. **Why Atrial Fibrillation is correct:** Due to its ability to increase the ERP and slow conduction, Quinidine is used for the **conversion and maintenance of sinus rhythm** in patients with atrial fibrillation or atrial flutter [1]. However, because it has vagolytic (antimuscarinic) effects, it can paradoxically increase AV conduction; therefore, it must be administered with an AV nodal blocking agent (like Digoxin or Beta-blockers) to prevent a rapid ventricular rate. 2. **Why other options are incorrect:** * **Hypertension:** Quinidine actually causes peripheral vasodilation (via alpha-blockade), which can lead to hypotension, but it is not a therapeutic agent for hypertension. * **Angina Pectoris:** It has no role in reducing myocardial oxygen demand or increasing supply. Beta-blockers or Calcium Channel Blockers are preferred here. * **Congestive Heart Failure (CHF):** Quinidine has a **negative inotropic effect**, which can worsen heart failure. **High-Yield Clinical Pearls for NEET-PG:** * **Cinchonism:** A classic side effect triad of tinnitus, headache, and dizziness. * **ECG Changes:** It causes **QT prolongation**, which carries a high risk of **Torsades de Pointes**. * **Drug Interaction:** Quinidine reduces the renal clearance of **Digoxin**, leading to Digoxin toxicity. * **Therapeutic Use:** While largely replaced by safer drugs, it remains a specific treatment for **Brugada Syndrome** and certain malaria strains.

Q: Which of the following statements best describes long-acting nitrate preparations?

Tolerance often develops. **Explanation:** **1. Why Option A is Correct:** Nitrate tolerance (tachyphylaxis) is a well-documented phenomenon where the therapeutic effect diminishes with continuous exposure. The underlying mechanism involves **oxidative stress**, leading to the depletion of **sulfhydryl (-SH) groups** required for the conversion of nitrates to Nitric Oxide (NO) and the inactivation of mitochondrial aldehyde dehydrogenase. To prevent this, a **"nitrate-free interval"** of 8–12 hours (usually at night) is clinically mandated to restore tissue sensitivity. **2. Why the Other Options are Incorrect:** * **Option B:** The mechanism of action of nitrates (cGMP-mediated vasodilation) is independent of beta-receptors. In fact, beta-blockers are often combined with nitrates to prevent reflex tachycardia. * **Option C:** Sublingual nitrates cause a rapid, high-peak plasma concentration leading to immediate meningeal vasodilation and "throbbing" headaches. Transdermal patches provide a slow, sustained release, making them *less* likely to cause acute, severe headaches compared to the sublingual route. * **Option D:** Oral nitrates undergo extensive **first-pass metabolism** in the liver (especially Nitroglycerin), making them significantly *less* potent and slower-acting than sublingual preparations, which bypass the liver and enter systemic circulation directly. **Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** Sublingual Nitroglycerin (GTN) is the DOC for acute anginal attacks; Isosorbide mononitrate is preferred for prophylaxis due to 100% bioavailability. * **Contraindication:** Never co-administer nitrates with **Sildenafil (PDE-5 inhibitors)** as it can lead to catastrophic hypotension. * **Storage:** GTN is volatile and light-sensitive; it should be stored in dark glass containers.

Q: Gemfibrozil produces hypolipidemic action by?

Increasing activity of lipoprotein lipase. Gemfibrozil belongs to the Fibrate class of hypolipidemic drugs. Its primary mechanism of action involves the activation of Peroxisome Proliferator-Activated Receptor-alpha (PPAR-α), a nuclear receptor [1]. 1. **Why Option A is Correct:** Activation of PPAR-α by Gemfibrozil leads to the increased transcription of the gene for Lipoprotein Lipase (LPL) [1]. LPL is the key enzyme responsible for the hydrolysis of triglycerides in VLDL and chylomicrons. By increasing LPL activity and down-regulating inhibitor proteins like apo C-III, Gemfibrozil significantly enhances the clearance of triglyceride-rich lipoproteins, making it the drug of choice for Hypertriglyceridemia [1]. 2. **Why Other Options are Incorrect:** * **Option B:** While fibrates do slightly decrease VLDL production, their *primary* and most potent action is the enhancement of LPL-mediated clearance [1]. * **Option C:** This is the primary mechanism of Statins (HMG-CoA reductase inhibitors) and PCSK9 inhibitors, which upregulate LDL receptors to lower serum LDL cholesterol. * **Option D:** This describes the mechanism of Bile Acid Sequestrants (e.g., Cholestyramine), which prevent bile acid reabsorption, forcing the liver to convert more cholesterol into bile acids. **High-Yield Clinical Pearls for NEET-PG:** * **Primary Effect:** Fibrates are the most effective drugs for lowering Triglycerides (TGs) and increasing HDL [1]. * **Adverse Effects:** Myopathy and Rhabdomyolysis (risk increases significantly when combined with Statins) [2], [3]. * **Contraindication:** Gemfibrozil should be avoided in patients with Gallstones (cholelithiasis) because it increases biliary cholesterol excretion. * **Drug Interaction:** Gemfibrozil inhibits the glucuronidation of Statins, leading to increased statin plasma levels and toxicity.

Q: Digoxin can accumulate to toxic levels in patients with?

Renal insufficiency. **Explanation:** The primary mechanism for the elimination of **Digoxin** is renal excretion. Approximately 60-80% of the drug is excreted unchanged in the urine via glomerular filtration and tubular secretion (mediated by P-glycoprotein). 1. **Why Renal Insufficiency is Correct:** Since Digoxin has a narrow therapeutic index (0.5–2 ng/mL) and is primarily cleared by the kidneys, any decrease in the Glomerular Filtration Rate (GFR) significantly increases its half-life (normally 36–40 hours). In patients with renal failure, the drug accumulates rapidly, leading to life-threatening digitalis toxicity. 2. **Why Other Options are Incorrect:** Digoxin undergoes minimal hepatic metabolism. Therefore, conditions like **Chronic Hepatitis** or **Advanced Cirrhosis** do not significantly alter its clearance. Similarly, **Chronic Pancreatitis** affects exocrine/endocrine functions of the pancreas but has no physiological role in the pharmacokinetics of Digoxin. **High-Yield Clinical Pearls for NEET-PG:** * **Hypokalemia:** This is the most important predisposing factor for Digoxin toxicity because K+ and Digoxin compete for the same binding site on the Na+/K+-ATPase pump. * **Drug Interactions:** Drugs like **Quinidine, Verapamil, and Amiodarone** reduce the renal clearance of Digoxin and can precipitate toxicity. * **ECG Findings:** The earliest sign of toxicity is often PVCs; the most characteristic sign is "Reverse Tick" ST-segment depression; the most specific arrhythmia is **Atrial Tachycardia with AV block**. * **Antidote:** Digoxin-specific antibody fragments (**DigiFab/Digibind**).

Question 1

Which of the following calcium channel blockers has a predominant peripheral action?

Accepted Answer

Nifedipine

Answer

Verapamil

Answer

Diltiazem

Answer

Nor-verapamil

Question 2

Which drug used in the treatment of peripheral vascular disease acts by increasing the flexibility of the RBC membrane and improving microcirculation?

Accepted Answer

Pentoxifylline

Answer

Cyclandelate

Answer

Xanhinol nicotinate

Answer

Cilostazole

Question 3

Quinidine is used to treat which of the following conditions?

Accepted Answer

Atrial fibrillation

Answer

Hypertension

Answer

Angina pectoris

Answer

Congestive heart failure

Question 4

Which of the following statements best describes long-acting nitrate preparations?

Accepted Answer

Tolerance often develops

Answer

Their effect can be blocked by high doses of beta selective inhibitors

Answer

Transdermal patches are more likely to be associated with headaches than are sublingual nitrates

Answer

Oral preparations are more effective than sublingual ones

Question 5

Why are statins typically administered at night?

Accepted Answer

HMG-CoA reductase activity exhibits its peak during midnight.

Answer

Statins achieve maximum absorption at night.

Answer

The potency of statins is enhanced during the night.

Answer

It is more convenient for patients to remember to take them at night.

Question 6

Which of the following drugs is used for the management of Supraventricular tachycardia?

Accepted Answer

Adenosine

Answer

Amiodarone

Answer

Naloxone

Answer

Calcium gluconate

Question 7

Gemfibrozil produces hypolipidemic action by?

Accepted Answer

Increasing activity of lipoprotein lipase

Answer

Decreased production of VLDL

Answer

Increase LDL receptors on hepatocytes

Answer

Increased conversion of cholesterol to bile acids

Question 8

A patient on ACE inhibitors developed a rash. What is the true statement regarding this situation?

Accepted Answer

The drug may be the cause, and discontinuation may improve the skin condition.

Answer

High-dose steroids are needed initially.

Answer

ACE inhibitors are safe and cannot lead to skin eruptions.

Answer

The drug may be the cause, but discontinuation is not required.

Question 9

A patient with Prinzmetal's angina is treated with isosorbide mononitrate. What is the mechanism of action of nitrates in this condition?

Accepted Answer

Endothelium-independent coronary vasodilation

Answer

Reduced cardiac contractility

Answer

Increased left ventricular end diastolic volume

Answer

Decreased diastolic perfusion pressure

Question 10

Digoxin can accumulate to toxic levels in patients with?

Accepted Answer

Renal insufficiency

Answer

Chronic hepatitis

Answer

Advanced cirrhosis

Answer

Chronic pancreatitis

Cardiovascular Drugs — MCQs

Cardiovascular Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?